Characterization of immune responses to two and three doses of the adenoviral vectored vaccine ChAdOx1 nCov-19 and the whole virion inactivated vaccine BBV152 in a mix-and-match study in India.

Vaccine · 2023 · PMC10289125 · PMID 37357073

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may not be significantno p-value reported

However, as the anti-nucleocapsid IgG levels were not seen to be significantly elevated in this group as compared to the ChAd recipients who completed their day 28 visit much before the start of the Omicron wave in India, the impact of the Omicron wave may not be significant on immune responses in Group 3.

also in 1,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.